$14.13
-0.80-5.36%
At close: -
$14.13
0.000.00%
After Hours: Apr 25, 4:00 PM EDT
Comments
Loading...
Spyre Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SYRE | Benzinga
Spyre Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.820
Quarterly Revenue Estimate
$4.00M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Spyre Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics | -$1.20 | -$0.82 | — | — | $0.00 | $4.00M | — | — | 05/08/2025 | Get Alert |
| SYRE | Spyre Therapeutics | -$4.05 | -$0.97 | -$0.81 | 16.49% | $0.00 | $2.33M | $0.00 | -100.00% | 02/27/2025 | Get Alert |
| SYRE | Spyre Therapeutics | -$9.34 | -$0.83 | -$1.36 | -63.86% | $0.00 | — | $0.00 | — | 11/07/2024 | Get Alert |
| SYRE | Spyre Therapeutics | -$41.50 | -$0.95 | -$0.86 | 9.47% | $688.00K | — | $0.00 | — | 08/07/2024 | Get Alert |
| SYRE | Spyre Therapeutics | -$5.00 | -$1.17 | -$1.20 | -2.56% | $198.00K | — | $0.00 | — | 05/09/2024 | Get Alert |
| SYRE | Spyre Therapeutics | -$5.00 | -$0.78 | -$4.05 | -419.23% | $168.00K | $220.00K | $0.00 | -100.00% | 02/29/2024 | Get Alert |
| SYRE | Spyre Therapeutics | -$4.75 | -$0.84 | -$9.34 | -1011.90% | $174.00K | — | $0.00 | — | 11/09/2023 | Get Alert |
| SYRE | Aeglea BioTherapeutics | -$6.75 | -$3.75 | -$41.50 | -1006.67% | $625.00K | $200.00K | $688.00K | 244.00% | 08/11/2023 | Get Alert |
| SYRE | Spyre Therapeutics | -$9.25 | -$4.50 | -$5.00 | -11.11% | $1.36M | $120.00K | $198.00K | 65.00% | 05/11/2023 | Get Alert |
| SYRE | Spyre Therapeutics | -$7.75 | -$5.00 | -$4.50 | 10.00% | $3.64M | $60.00K | $168.00K | 180.00% | 03/02/2023 | Get Alert |
| SYRE | Spyre Therapeutics | -$7.75 | -$5.75 | -$4.75 | 17.39% | $1.40M | $210.00K | $174.00K | -17.14% | 11/03/2022 | Get Alert |
| SYRE | Spyre Therapeutics | -$2.50 | -$7.75 | -$6.75 | 12.90% | $0.00 | — | $625.00K | — | 08/04/2022 | Get Alert |
| SYRE | Spyre Therapeutics | -$7.00 | -$8.50 | -$9.25 | -8.82% | $0.00 | $1.32M | $1.36M | 3.18% | 05/05/2022 | Get Alert |
| SYRE | Spyre Therapeutics | -$8.50 | -$7.25 | -$7.75 | -6.90% | $0.00 | $3.07M | $3.64M | 18.70% | 03/08/2022 | Get Alert |
| SYRE | Spyre Therapeutics | -$7.25 | -$7.00 | -$7.75 | -10.71% | $0.00 | $4.05M | $1.40M | -65.46% | 11/04/2021 | Get Alert |
| SYRE | Spyre Therapeutics | -$10.00 | -$4.00 | -$2.50 | 37.50% | $0.00 | — | $0.00 | — | 08/05/2021 | Get Alert |
| SYRE | Spyre Therapeutics | -$14.25 | -$4.25 | -$7.00 | -64.71% | $0.00 | — | $0.00 | — | 05/10/2021 | Get Alert |
| SYRE | Spyre Therapeutics | -$16.25 | -$7.75 | -$8.50 | -9.68% | $0.00 | — | $0.00 | — | 03/18/2021 | Get Alert |
| SYRE | Spyre Therapeutics | -$16.50 | -$9.75 | -$7.25 | 25.64% | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| SYRE | Spyre Therapeutics | -$13.75 | -$11.00 | -$10.00 | 9.09% | $0.00 | — | $0.00 | — | 08/10/2020 | Get Alert |
| SYRE | Spyre Therapeutics | -$14.75 | -$16.50 | -$14.25 | 13.64% | $0.00 | — | $0.00 | — | 05/07/2020 | Get Alert |
Spyre Therapeutics (SYRE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.81 | $-0.97 | 16.5 % |
| Q3 | 2024-11-07 | $-1.36 | $-0.83 | -63.9 % |
| Q2 | 2024-08-07 | $-0.86 | $-0.95 | 9.47 % |
| Q1 | 2024-05-09 | $-1.20 | $-1.17 | -2.56 % |
Spyre Therapeutics (SYRE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $0 | $2.33M | -100.0 % |
| Q4 | 2024-02-29 | $0 | $220.00K | -100.0 % |
| Q2 | 2023-08-11 | $688.00K | $200.00K | 244.0 % |
| Q1 | 2023-05-11 | $198.00K | $120.00K | 65.0 % |
FAQ
When is Spyre Therapeutics (NASDAQ:SYRE) reporting earnings?
Spyre Therapeutics (SYRE) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Spyre Therapeutics (NASDAQ:SYRE)?
The Actual EPS was $-0.81, which beat the estimate of $-0.97.
What were Spyre Therapeutics’s (NASDAQ:SYRE) revenues?
The Actual Revenue was $0K, which missed the estimate of $2.3M.
Browse earnings estimates, EPS, and revenue on all stocks.
